49

DAFTAR PUSTAKA

1. Nurdjanah S. Sirosis hati. Dalam: Sudoyo WA, Setiyohadi B, Alwi I, et al,

editor. Buku ajar ilmu penyakit dalam jilid I. Edisi keempat. Jakarta: Pusat
Penerbitan Departemen Ilmu Penyakit Dalam FK UI, 2007.
2. Thorn, Adams, Braunwald, Isselbacher, & Petersdorf. Harrison's Principles of
Internal Medicine. Edisi IX. Jakarta Utara: Penerbit Buku Kedokteran; 1991.
3. The Global Burden Of Deseases 2004 [database on the internet]. WHO. 2008
[cited 16 November 2013]. Available from: www.who.int/evidence/bod.
4. Liver cirrhosis mortality rates in Britain from 1950 to 2002 an analysis of
routine data [database on the internet]. Leon,D. 2006 [cited 2 Desember
2013]. Available from: http:// www.thelancet.com.
5. Statistics About Liver of Cirrhosis [database on the internet]. NCHS. 2003
[cited 5 November 2013]. Available from:
http://www.wrongdiagnosis.com/c/cirrhosis_of_the_liver/stats.htm.
6. National Vital Statistics Reports [database on the internet]. Xu dkk. 2010
[cited 16 Desember 2013]. Available from:
http://www.cdc.gov/nchs/data_access/Vitalstatsonline.htm.
7. Muttaqin, A., & Sari, K. Gangguan Gastrointestinal. Jakarta: Penerbit
Salemba Medika; 2011.
8. Farrell, G. C., 2008, Cirrhosis in Asians: Less common than in Europeans
Journal of Gastroenterology and Hepatology, Volume 23, Issue 4, pages 508–
511 http://onlinelibrary.wiley.com/doi.
9. Kusumobroto O Hernomo. Sirosis Hati dalam buku ajar Ilmu Penyakit Hati.
Edisi I. Jakarta: Jayabadi; 2007.
10. Karina. Faktor Risiko Kematian Penderita Sirosis Hati Di RSUP Dr. Kariadi
Semarang Tahun 2002–2006, Jurnal Media Medika Muda [internet]. 2007
[cited 2014 Maret 11]. Available from:
http://eprints.undip.ac.id/view/divisions/sch=5Fmed/2007.html#group_K.
11. Sulaiman A. Gasrtoenterologi Hepatologi. Jakarta: CV. Sagung Seto; 1997.
 50

12. Global Burden of Viral Hepatitis [database on the internet]. WHO Geneva.
2010 [cited 12 Desember 2013]. Available from: http://
www.who.int/evidence/bod.
13. Hepatitis B and HIV Coinfecton Clinical Protocol [database on the internet].
WHO European Region. 2010 [cited 16 Desember 2013].
14. Laporan Hasil Riset Kesehatan Dasar RISKESDAS Indonesia [database on
the internet]. Departemen Kesehatan. 2007 [ cited 2 Januari 2014].
15. Profil Kesehatan 2008 [database on the internet]. Departemen Kesehatan.
2009 [cited 2 Januari 2014]. Available from: http//www.depkes.go.id .
16. Setiawati, M. Perbandingan Validitas Maddrey’s Discriminant Function dan
Skor Child-Pugh dalam Memprediksi Ketahanan Hidup 12 Minggu pada
Pasien Sirosis Hepatis. Semarang: Fakultas Kedokteran Universitas
Diponegoro; 2009.
17. Deep vein thrombosis in patient with cirrhosis [database on the internet].
Lesmana, dkk. 2009 [cited 16 Januari 2014]. Available from:
http://www.who.int/research/en.
18. Simamora, C. T. Hubungan Komplikasi, Skor Child-Turcotte dan Usia Lanjut
Sebagai Faktor Resiko Kematian Pada Pasien Sirosis Hati di RSUD Dr.
Soedarso Pontianak. Pontianak; 2013.
19. Malau, A. S. Karakteristik Penderita Sirosis Hati Yang Dirawat Inap Di
Rumah Sakit Martha Friska Medan Tahun 2006-2010. Medan; 2011.
20. Report of The Regional Committee for the Eastern Mediterranean Fifty-sixth
Session Fez, Morocco 5–8 October 2009 [database on the internet]. Mohsni.
2009 [cited 6 Pebruari 2014]. Available from: http://search.who.int/.
21. Statistics by Country for Cirrhosis of the liver [database on the internet]. US
Census Bureau, International Data Base. 2005 [cited 11 Januari 2014].
Available from: http://www.cureresearch.com/c/cirrhosis_of_the_liver/stats-
country_ printer.htm.
22. Ndraha. The Indonesian Journal of Gastroenterology, Hepatology, and
Digestive Endoscopy. Volume 10, Number 3; 2009.
23. Hadi, S. Gastroenterologi. Bandung: Penerbit Alumni Bandung; 2002.
 51

24. Liver cirrhosis–Epidemiological and Clinical Aspects Department of Internal

Medicine Sahlgrenska University Hospital, Goteborg University, Sweden
[database on the internet]. Gunnarsdottir. 2008 [cited 3 Pebruari 2014].
Available from: www.gupea.ub.gu.se/bitstream/2077/10132/1/Ramen-Avh-
SAG.pdf.
25. Rasyid. Temuan Ultrasonografi Kanker Hati Hepatoseluler Hepatoma.
Majalah Kedokteran Nusantara. Volume 39 No 2; 2006.
26. Sulaiman A. Harapan Baru Dalam Penatalaksanaan Sirosis Hati, Dalam
Pertemuan Ilmiah Tahunan Perkembangan Muktahir Ilmu Penyakit Dalam.
Jakarta: Balai Penerbit FK UI; 2003.
27. Death Rates [database on the internet]. WHO. 2004 [cited 8 Pebruari 2014].
Available from: http://www.who.int.
28. Studi Penggunaan Obat Pada Pasien Sirosis Hepatik [database on the internet].
Rencianisari. 2008 [cited 4 Pebruari 2014]. Available from:
http://adln.lib.unair.ac.id/go.php?id=gdlhub-gdl-s1-2011-.
29. Percentage of total deaths, death rates, age-adjusted death rates for 2007,
percentage change in age-adjusted death rates in 2007 from 2006, and ratio of
age-adjusted death rates, by race and sex for the 15 leading causes of death
for the total population in 2007 [database on the internet]. National Vital
Statistics Reports. 2010 [cited 15 Pebruari 2014]. Available from:
http://www.cdc.gov/nchs.
30. Avunduk, C. Manual of Gastroenterology Diagnosis and Therapy. Edisi IV.
Philadelphia: Lippincott Williams & Wilkins; 2008.
31. Sherlock S, Dooley J. Disease of the liver and biliary system. Edisi IX.
Oxford: Blackwell Scientific Publications, 1993: 357-67.
32. Rigas B, Spiro HM. Clinical Gastroenterology: companion book. Edisi IV.
New York: Mc Graw Hill, 1995: 588-611.
33. Global Burden of Diseases in 2002 [database on the internet]. WHO Global.
2008 [cited 9 Pebruari 2014]. Available from: http://www.wpro.who.int.
 52

34. Arguedes MR, Fallon MB. Cirrhosis of the liver and its complications. In:
Carpenter CCJ, Griggs RC, Loscalzo J, editors. Cecil essentials of medicine.
Edisi XI. Pennsylvania: Saunders, 2004: 411-7.
35. Price S.A. Patofisiologi konsep Klinis Proses-proses Penyakit, Edisi VI.
Jakarta: EGC; 2006.
36. Kayacetin E, Efe D, Dogan C. Portal and splenic hemodynamics in cirrhotic
patients: relationship between esophageal variceal bleeding and the severity
of hepatic failure. Journal of Gastroenterology, 2004; 39: 661-7.
37. Friedman SL, McQuaid KR, Grendell JH. Current diagnosis and treatment in
gastroenterology. 2nd ed. New York: Mc Graw Hill, 2003: 644-62.
38. Porth CM. Pathophysiology: concepts of altered health states. 5th ed.
Philadelphia, 1998: 761-6.
39. Weiss GR. Clinical oncology. Connecticut: Appleton & Lange; 1993.
40. Cardenas A, Arroyo V. Mechanism of water and sodium retension in
cirrhosis and the phatogenesis of ascites. Best Pract Res Clin Endokrinol
Metab 2003; 17: 607-22.
41. Cheney CP, Goldberg EM, Chopra S. Cirrhosis and portal hypertension: an
overview. In: Friedman LS, Keeffe EB, editors. Handbook of liver disease.
2nd ed. China: Churchill Livingstone, 2004: 125-37.
42. Gilroy J. Basic neurology. 3rd ed. New York: Mc Graw Hill, 2000: 517-8.
43. Hassan HA. Spontaneous Bacterial Peritonitis. Dalam: Adi S, editor. Naskah
lengkap pendidikan kedokteran berkelanjutan XVI. Surabaya: Laboratorium
SMF Penyakit Dalam FK Unair RSUD Dr. Sutomo, 2001: 41-59.
44. Hirlan. Nutrisi enteral dan parenteral pada penderita penyakit hati kronik.
Dalam: Soeroso S, Haryoko W, Setiati TE, Kosim HMS, Triwara B, editor.
Gizi klinik: Nutrisi enteral dan parenteral. Badan Penerbit Universitas
Diponegoro; 1994.
45. Doubatty, AC. 2009. Perbandingan validitas skor mayo end stage liver
disease dan skor child-pugh dalam memprediksi ketahanan hidup 12 minggu
pada pasien sirosis hepatis. Semarang: Universitas Diponegoro.
 53

46. Shibli, AB; Tachauer, A; Mohanty, SR.; 2006, Outpatient Management of

Cirrhosis, Southern Medicaal Journal, 99 (6), 559-561.
47. Clinical profile of patients with cirrhosis of liver in a tertiary carehospital,
Dharan, Nepal [database on the internet]. Maskey R, Karki P, Ahmed S V,
Manandhar D N. 2011 [cited 3 Maret 2014]. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/22364095.
48. Sarin SK, Chari S, Sundaram KR, Ahuja RK, Anand BS, Broor SL. Young
versus adult cirrhosis: a prospective comparative analysis of the clinical
profile, natural course and survival. Gut 1988; 29: 101-7.
49. Etiology of Liver Cirrhosis in Mexico [database on the internet]. Méndez-
Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juárez A, Castañeda B,
et al. 2004 [cited 22 Juli 2014]. Available from:
http://new.medigraphic.com/cgibin/resumenMainI.cgi?IDARTICULO=12532.
50. Complications of liver cirrhosis [database on the internet]. Wittenburg H,
Tennert U, Berg T. 2011 [cited 22 Juli 2014]. Available from:
http://europepmc.org/abstract/MED/21611819.
 54

Lampiran 1. Analisis Univariat beberapa Variabel

Statistics

Albumin Lama
Usia Bilirubin Total serum PPT perawatan
N Valid 303 245 259 226 303
Missing 2 60 46 79 2
Mean 54.17 4.4606 2.3448 8.1827 10.46
Median 54.00 1.9800 2.3000 5.3000 9.00
St d. Dev iation 11.755 5.92105 .60094 12.46432 7.626
Minimum 16 .11 .90 -.90 0
Maximum 81 36.31 4.66 106.30 48

NPar Tests

One-Sample Kolmogorov-Smirnov Test

Albumin Lama
Usia Bilirubin Total serum PPT perawatan
N 303 245 259 226 303
Normal Parameters a,b Mean 54.17 4.4606 2.3448 8.1827 10.46
St d. Dev iation 11.755 5.92105 .60094 12.46432 7.626
Most Extreme Absolute .062 .231 .064 .239 .145
Dif f erences Positiv e .062 .221 .064 .232 .145
Negativ e -.055 -.231 -.040 -.239 -.101
Kolmogorov -Smirnov Z 1.080 3.620 1.023 3.589 2.522
Asy mp. Sig. (2-tailed) .193 .000 .246 .000 .000
a. Test distribution is Normal.
b. Calculated f rom data.
 55

Frequency Table

Jenis kel amin

Cumulat iv e
Frequency Percent Valid Percent Percent
Valid Laki-laki 205 67,7 67,7 67,7
Perempuan 98 32,3 32,3 100,0
Total 303 100,0 100,0

Usia

Cumulat iv e
Frequency Percent Valid Percent Percent
Valid < 31 10 3.3 3.3 3.3
31 - 40 21 6.9 6.9 10.2
41 - 50 79 26.1 26.1 36.3
51 - 60 104 34.3 34.3 70.6
61 - 70 59 19.5 19.5 90.1
> 70 30 9.9 9.9 100.0
Total 303 100.0 100.0

HBV

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 184 60.7 60.7 60.7
Tidak 119 39.3 39.3 100.0
Total 303 100.0 100.0

HCV

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 55 18.2 18.2 18.2
Tidak 248 81.8 81.8 100.0
Total 303 100.0 100.0
 56

NAFL

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 21 6.9 6.9 6.9
Tidak 282 93.1 93.1 100.0
Total 303 100.0 100.0

Alkohol

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Tidak 303 100.0 100.0 100.0

Lain-lain

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 59 19.5 19.5 19.5
Tidak 244 80.5 80.5 100.0
Total 303 100.0 100.0

Klasifikasi CHILD-PUGH

Cumulat iv e
Frequency Percent Valid Percent Percent
Valid A 15 5,0 6,4 6,4
B 75 24,8 32,1 38,5
C 144 47,5 61,5 100,0
Total 234 77,2 100,0
Missing Sy stem 69 22,8
Total 303 100,0
 57

Perdarahan var. Esof

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 59 19,5 19,5 19,5
Tidak 244 80,5 80,5 100,0
Total 303 100,0 100,0

Ensefalopati Hepatikum

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 66 21,8 21,8 21,8
Tidak 237 78,2 78,2 100,0
Total 303 100,0 100,0

Karsinoma Hepatoseluler

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 34 11,2 11,2 11,2
Tidak 269 88,8 88,8 100,0
Total 303 100,0 100,0

Sindr. Hepatorenal

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 5 1,7 1,7 1,7
Tidak 298 98,3 98,3 100,0
Total 303 100,0 100,0
 58

Hematemesis

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 79 26,1 26,1 26,1
Tidak 224 73,9 73,9 100,0
Total 303 100,0 100,0

Melena

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 85 28,1 28,1 28,1
Tidak 218 71,9 71,9 100,0
Total 303 100,0 100,0

Ascites

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 224 73,9 73,9 73,9
Tidak 79 26,1 26,1 100,0
Total 303 100,0 100,0

Peritonitis bakterial spontan

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 1 ,3 ,3 ,3
Tidak 302 99,7 99,7 100,0
Total 303 100,0 100,0

Gastropati HT Porta

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 39 12,9 12,9 12,9
Tidak 264 87,1 87,1 100,0
Total 303 100,0 100,0
 59

Efusi pleura

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 38 12,5 12,5 12,5
Tidak 265 87,5 87,5 100,0
Total 303 100,0 100,0

Pneumonia

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 37 12,2 12,2 12,2
Tidak 266 87,8 87,8 100,0
Total 303 100,0 100,0

TB paru

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 5 1,7 1,7 1,7
Tidak 298 98,3 98,3 100,0
Total 303 100,0 100,0

Syok

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 7 2,3 2,3 2,3
Tidak 296 97,7 97,7 100,0
Total 303 100,0 100,0
 60

Sepsi s

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 19 6,3 6,3 6,3
Tidak 284 93,7 93,7 100,0
Total 303 100,0 100,0

Penyakit ginjal

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 10 3,3 3,3 3,3
Tidak 293 96,7 96,7 100,0
Total 303 100,0 100,0

Penyakit jantung

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 3 1,0 1,0 1,0
Tidak 300 99,0 99,0 100,0
Total 303 100,0 100,0

Survival rate

Cumulat iv e
Frequency Percent Valid Percent Percent
Valid Meninggal 60 19,8 19,8 19,8
Hidup 243 80,2 80,2 100,0
Total 303 100,0 100,0

Perut membesar

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 111 36.4 36.4 36.4
Tidak 194 63.6 63.6 100.0
Total 305 100.0 100.0
 61

Nyeri perut

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 17 5.6 5.6 5.6
Tidak 288 94.4 94.4 100.0
Total 305 100.0 100.0

Berak darah

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 32 10.5 10.5 10.5
Tidak 273 89.5 89.5 100.0
Total 305 100.0 100.0

Muntah darah

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 63 20.7 20.7 20.7
Tidak 242 79.3 79.3 100.0
Total 305 100.0 100.0

Badan lemas

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 15 4.9 4.9 4.9
Tidak 290 95.1 95.1 100.0
Total 305 100.0 100.0

Penurunan kesadaran

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 18 5.9 5.9 5.9
Tidak 287 94.1 94.1 100.0
Total 305 100.0 100.0
 62

Mata kuni ng

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 13 4.3 4.3 4.3
Tidak 292 95.7 95.7 100.0
Total 305 100.0 100.0

Lain2

Cumulativ e
Frequency Percent Valid Percent Percent
Valid Ya 48 15.7 15.7 15.7
Tidak 257 84.3 84.3 100.0
Total 305 100.0 100.0

Ensefalopati

Cumulat iv e
Frequency Percent Valid Percent Percent
Valid grade I-I I 32 10.5 44.4 44.4
grade III -IV 40 13.1 55.6 100.0
Total 72 23.6 100.0
Missing Sy stem 233 76.4
Total 305 100.0

Ascites

Cumulat iv e
Frequency Percent Valid Percent Percent
Valid ringan-sedang 180 59.0 80.4 80.4
berat 44 14.4 19.6 100.0
Total 224 73.4 100.0
Missing Sy stem 81 26.6
Total 305 100.0
 63

Lampiran 2. Analisis Bivariat beberapa Variabel terhadap Survival Rate

Jenis kelamin * Survival rate Crosstabul ation

Surv iv al rate
Meninggal Hidup Total
Jenis kelamin Laki-laki Count 39 166 205
% wit hin Surv iv al rate 65,0% 68,3% 67,7%
% of Total 12,9% 54,8% 67,7%
Perempuan Count 21 77 98
% wit hin Surv iv al rate 35,0% 31,7% 32,3%
% of Total 6,9% 25,4% 32,3%
Total Count 60 243 303
% wit hin Surv iv al rate 100,0% 100,0% 100,0%
% of Total 19,8% 80,2% 100,0%
 64

HBV * Survival rate Crosstabul ation

Surv iv al rate
Meninggal Hidup Total
HBV Ya Count 35 149 184
% wit hin Surv iv al rat e 58.3% 61.3% 60.7%
% of Total 11.6% 49.2% 60.7%
Tidak Count 25 94 119
% wit hin Surv iv al rat e 41.7% 38.7% 39.3%
% of Total 8.3% 31.0% 39.3%
Total Count 60 243 303
% wit hin Surv iv al rat e 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

HCV * Survival rate Crosstabul ation

Surv iv al rate
Meninggal Hidup Total
HCV Ya Count 8 47 55
% wit hin Surv iv al rat e 13.3% 19.3% 18.2%
% of Total 2.6% 15.5% 18.2%
Tidak Count 52 196 248
% wit hin Surv iv al rat e 86.7% 80.7% 81.8%
% of Total 17.2% 64.7% 81.8%
Total Count 60 243 303
% wit hin Surv iv al rat e 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

NAFL * Survi val rate Crosstabulation

Surv iv al rate
Meninggal Hidup Total
NAFL Ya Count 3 18 21
% wit hin Surv iv al rat e 5.0% 7.4% 6.9%
% of Total 1.0% 5.9% 6.9%
Tidak Count 57 225 282
% wit hin Surv iv al rat e 95.0% 92.6% 93.1%
% of Total 18.8% 74.3% 93.1%
Total Count 60 243 303
% wit hin Surv iv al rat e 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%
 65

Alkohol * Survival rate Crosstabul ation

Surv iv al rate
Meninggal Hidup Total
Alkohol Tidak Count 60 243 303
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%
Total Count 60 243 303
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Lain-lain * Survi val rate Crosstabulation

Surv iv al rate
Meninggal Hidup Total
Lain-lain Ya Count 18 41 59
% within Surv iv al rate 30.0% 16.9% 19.5%
% of Total 5.9% 13.5% 19.5%
Tidak Count 42 202 244
% within Surv iv al rate 70.0% 83.1% 80.5%
% of Total 13.9% 66.7% 80.5%
Total Count 60 243 303
% within Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%
 66

Klasifikasi CHILD-PUGH * Survi val rate Crosstabulation

Surv iv al rate
Meninggal Hidup Total
Klasif ikasi A Count 0 15 15
CHI LD-PUGH % within Surv iv al rate ,0% 8,2% 6,4%
% of Total ,0% 6,4% 6,4%
B Count 4 71 75
% within Surv iv al rate 7,7% 39,0% 32,1%
% of Total 1,7% 30,3% 32,1%
C Count 48 96 144
% within Surv iv al rate 92,3% 52,7% 61,5%
% of Total 20,5% 41,0% 61,5%
Total Count 52 182 234
% within Surv iv al rate 100,0% 100,0% 100,0%
% of Total 22,2% 77,8% 100,0%
 67

Usia * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Usia < 31 Count 1 9 10
Expected Count 2.0 8.0 10.0
% wit hin Surv iv al rate 1.7% 3.7% 3.3%
% of Total .3% 3.0% 3.3%
31 - 40 Count 3 18 21
Expected Count 4.2 16.8 21.0
% wit hin Surv iv al rate 5.0% 7.4% 6.9%
% of Total 1.0% 5.9% 6.9%
41 - 50 Count 15 64 79
Expected Count 15.6 63.4 79.0
% wit hin Surv iv al rate 25.0% 26.3% 26.1%
% of Total 5.0% 21.1% 26.1%
51 - 60 Count 19 85 104
Expected Count 20.6 83.4 104.0
% wit hin Surv iv al rate 31.7% 35.0% 34.3%
% of Total 6.3% 28.1% 34.3%
61 - 70 Count 15 44 59
Expected Count 11.7 47.3 59.0
% wit hin Surv iv al rate 25.0% 18.1% 19.5%
% of Total 5.0% 14.5% 19.5%
> 70 Count 7 23 30
Expected Count 5.9 24.1 30.0
% wit hin Surv iv al rate 11.7% 9.5% 9.9%
% of Total 2.3% 7.6% 9.9%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig.

Value df (2-sided)
Pearson Chi-Square 2.604a 5 .761
Likelihood Ratio 2.663 5 .752
Linear-by -Linear
1.882 1 .170
Association
N of Valid Cases 303
a. 2 cells (16.7%) hav e expected count less t han 5. The
minimum expected count is 1.98.
 68

Efusi pleura * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Ef usi pleura Ya Count 3 35 38
Expected Count 7.5 30.5 38.0
% wit hin Surv iv al rate 5.0% 14.4% 12.5%
% of Total 1.0% 11.6% 12.5%
Tidak Count 57 208 265
Expected Count 52.5 212.5 265.0
% wit hin Surv iv al rate 95.0% 85.6% 87.5%
% of Total 18.8% 68.6% 87.5%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 3.879b 1 .049
Continuity Correctiona 3.069 1 .080
Likelihood Ratio 4.649 1 .031
Fisher's Exact Test .051 .032
Linear-by -Linear
3.866 1 .049
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 7.
52.
 69

Pneumonia * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Pneumonia Ya Count 15 22 37
Expected Count 7.3 29.7 37.0
% wit hin Surv iv al rate 25.0% 9.1% 12.2%
% of Total 5.0% 7.3% 12.2%
Tidak Count 45 221 266
Expected Count 52.7 213.3 266.0
% wit hin Surv iv al rate 75.0% 90.9% 87.8%
% of Total 14.9% 72.9% 87.8%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 11.414b 1 .001
Continuity Correctiona 9.975 1 .002
Likelihood Ratio 9.780 1 .002
Fisher's Exact Test .002 .002
Linear-by -Linear
11.377 1 .001
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 7.
33.
 70

TB paru * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
TB paru Ya Count 0 5 5
Expected Count 1.0 4.0 5.0
% wit hin Surv iv al rate .0% 2.1% 1.7%
% of Total .0% 1.7% 1.7%
Tidak Count 60 238 298
Expected Count 59.0 239.0 298.0
% wit hin Surv iv al rate 100.0% 97.9% 98.3%
% of Total 19.8% 78.5% 98.3%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 1.255b 1 .263
Continuity Correctiona .308 1 .579
Likelihood Ratio 2.227 1 .136
Fisher's Exact Test .587 .329
Linear-by -Linear
1.251 1 .263
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 2 cells (50.0%) hav e expected count less than 5. The minimum expected count is .
99.
 71

Syok * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Sy ok Ya Count 7 0 7
Expected Count 1.4 5.6 7.0
% wit hin Surv iv al rat e 11.7% .0% 2.3%
% of Total 2.3% .0% 2.3%
Tidak Count 53 243 296
Expected Count 58.6 237.4 296.0
% wit hin Surv iv al rat e 88.3% 100.0% 97.7%
% of Total 17.5% 80.2% 97.7%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rat e 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 29.020b 1 .000
Continuity Correctiona 24.081 1 .000
Likelihood Ratio 23.359 1 .000
Fisher's Exact Test .000 .000
Linear-by -Linear
28.925 1 .000
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 1 cells (25.0%) hav e expected count less than 5. The minimum expected count is 1.
39.
 72

Sepsis * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Sepsis Ya Count 18 1 19
Expected Count 3.8 15.2 19.0
% wit hin Surv iv al rate 30.0% .4% 6.3%
% of Total 5.9% .3% 6.3%
Tidak Count 42 242 284
Expected Count 56.2 227.8 284.0
% wit hin Surv iv al rate 70.0% 99.6% 93.7%
% of Total 13.9% 79.9% 93.7%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 71.676b 1 .000
Continuity Correctiona 66.730 1 .000
Likelihood Ratio 55.730 1 .000
Fisher's Exact Test .000 .000
Linear-by -Linear
71.439 1 .000
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 1 cells (25.0%) hav e expected count less than 5. The minimum expected count is 3.
76.
 73

Penyakit ginjal * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Peny akit Ya Count 4 6 10
ginjal Expected Count 2.0 8.0 10.0
% wit hin Surv iv al rate 6.7% 2.5% 3.3%
% of Total 1.3% 2.0% 3.3%
Tidak Count 56 237 293
Expected Count 58.0 235.0 293.0
% wit hin Surv iv al rate 93.3% 97.5% 96.7%
% of Total 18.5% 78.2% 96.7%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 2.657b 1 .103
Continuity Correctiona 1.504 1 .220
Likelihood Ratio 2.231 1 .135
Fisher's Exact Test .114 .114
Linear-by -Linear
2.648 1 .104
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 1 cells (25.0%) hav e expected count less than 5. The minimum expected count is 1.
98.
 74

Penyakit jantung * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Peny akit Ya Count 0 3 3
jantung Expected Count .6 2.4 3.0
% wit hin Surv iv al rate .0% 1.2% 1.0%
% of Total .0% 1.0% 1.0%
Tidak Count 60 240 300
Expected Count 59.4 240.6 300.0
% wit hin Surv iv al rate 100.0% 98.8% 99.0%
% of Total 19.8% 79.2% 99.0%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .748b 1 .387
Continuity Correctiona .019 1 .891
Likelihood Ratio 1.331 1 .249
Fisher's Exact Test 1.000 .515
Linear-by -Linear
.746 1 .388
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 2 cells (50.0%) hav e expected count less than 5. The minimum expected count is .
59.
 75

Perdarahan var. Esof * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Perdarahan Ya Count 7 52 59
v ar. Esof Expected Count 11.7 47.3 59.0
% wit hin Surv iv al rate 11.7% 21.4% 19.5%
% of Total 2.3% 17.2% 19.5%
Tidak Count 53 191 244
Expected Count 48.3 195.7 244.0
% wit hin Surv iv al rate 88.3% 78.6% 80.5%
% of Total 17.5% 63.0% 80.5%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 2.907b 1 .088
Continuity Correctiona 2.319 1 .128
Likelihood Ratio 3.197 1 .074
Fisher's Exact Test .102 .059
Linear-by -Linear
2.897 1 .089
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 11.
68.
 76

Ensefalopati Hepatikum * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Ensef alopati Ya Count 41 25 66
Hepatikum Expected Count 13.1 52.9 66.0
% wit hin Surv iv al rate 68.3% 10.3% 21.8%
% of Total 13.5% 8.3% 21.8%
Tidak Count 19 218 237
Expected Count 46.9 190.1 237.0
% wit hin Surv iv al rate 31.7% 89.7% 78.2%
% of Total 6.3% 71.9% 78.2%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 95.157b 1 .000
Continuity Correctiona 91.781 1 .000
Likelihood Ratio 81.663 1 .000
Fisher's Exact Test .000 .000
Linear-by -Linear
94.843 1 .000
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 13.
07.
 77

Karsinoma Hepatoseluler * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Karsinoma Hepatoseluler Ya Count 5 29 34
Expected Count 6.7 27.3 34.0
% wit hin Surv iv al rate 8.3% 11.9% 11.2%
% of Total 1.7% 9.6% 11.2%
Tidak Count 55 214 269
Expected Count 53.3 215.7 269.0
% wit hin Surv iv al rate 91.7% 88.1% 88.8%
% of Total 18.2% 70.6% 88.8%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .626b 1 .429
Continuity Correctiona .317 1 .573
Likelihood Ratio .668 1 .414
Fisher's Exact Test .502 .296
Linear-by -Linear
.624 1 .429
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 6.
73.
 78

Sindr. Hepatorenal * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Sindr. Hepatorenal Ya Count 2 3 5
Expected Count 1.0 4.0 5.0
% wit hin Surv iv al rate 3.3% 1.2% 1.7%
% of Total .7% 1.0% 1.7%
Tidak Count 58 240 298
Expected Count 59.0 239.0 298.0
% wit hin Surv iv al rate 96.7% 98.8% 98.3%
% of Total 19.1% 79.2% 98.3%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 1.306b 1 .253
Continuity Correctiona .333 1 .564
Likelihood Ratio 1.093 1 .296
Fisher's Exact Test .258 .258
Linear-by -Linear
1.302 1 .254
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 2 cells (50.0%) hav e expected count less than 5. The minimum expected count is .
99.
 79

Hematemesis * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Hematemesis Ya Count 17 62 79
Expected Count 15.6 63.4 79.0
% wit hin Surv iv al rate 28.3% 25.5% 26.1%
% of Total 5.6% 20.5% 26.1%
Tidak Count 43 181 224
Expected Count 44.4 179.6 224.0
% wit hin Surv iv al rate 71.7% 74.5% 73.9%
% of Total 14.2% 59.7% 73.9%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .198b 1 .656
Continuity Correctiona .079 1 .779
Likelihood Ratio .196 1 .658
Fisher's Exact Test .743 .384
Linear-by -Linear
.198 1 .657
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 15.
64.
 80

Melena * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Melena Ya Count 18 67 85
Expected Count 16.8 68.2 85.0
% wit hin Surv iv al rate 30.0% 27.6% 28.1%
% of Total 5.9% 22.1% 28.1%
Tidak Count 42 176 218
Expected Count 43.2 174.8 218.0
% wit hin Surv iv al rate 70.0% 72.4% 71.9%
% of Total 13.9% 58.1% 71.9%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .141b 1 .708
Continuity Correctiona .046 1 .830
Likelihood Ratio .139 1 .709
Fisher's Exact Test .749 .410
Linear-by -Linear
.140 1 .708
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 16.
83.
 81

Ascites * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Ascites Ya Count 47 177 224
Expected Count 44.4 179.6 224.0
% wit hin Surv iv al rate 78.3% 72.8% 73.9%
% of Total 15.5% 58.4% 73.9%
Tidak Count 13 66 79
Expected Count 15.6 63.4 79.0
% wit hin Surv iv al rate 21.7% 27.2% 26.1%
% of Total 4.3% 21.8% 26.1%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .753b 1 .385
Continuity Correctiona .495 1 .482
Likelihood Ratio .777 1 .378
Fisher's Exact Test .417 .243
Linear-by -Linear
.751 1 .386
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 15.
64.
 82

Peritonitis bakterial spontan * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Peritonitis bakterial Ya Count 1 0 1
spontan Expected Count .2 .8 1.0
% wit hin Surv iv al rate 1.7% .0% .3%
% of Total .3% .0% .3%
Tidak Count 59 243 302
Expected Count 59.8 242.2 302.0
% wit hin Surv iv al rate 98.3% 100.0% 99.7%
% of Total 19.5% 80.2% 99.7%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 4.063b 1 .044
Continuity Correctiona .576 1 .448
Likelihood Ratio 3.252 1 .071
Fisher's Exact Test .198 .198
Linear-by -Linear
4.050 1 .044
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 2 cells (50.0%) hav e expected count less than 5. The minimum expected count is .
20.
 83

Gastropati HT Porta * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Gastropati Ya Count 5 34 39
HT Porta Expected Count 7.7 31.3 39.0
% wit hin Surv iv al rate 8.3% 14.0% 12.9%
% of Total 1.7% 11.2% 12.9%
Tidak Count 55 209 264
Expected Count 52.3 211.7 264.0
% wit hin Surv iv al rate 91.7% 86.0% 87.1%
% of Total 18.2% 69.0% 87.1%
Total Count 60 243 303
Expected Count 60.0 243.0 303.0
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Chi-Square Tests

Asy mp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 1.374b 1 .241
Continuity Correctiona .916 1 .339
Likelihood Ratio 1.503 1 .220
Fisher's Exact Test .288 .170
Linear-by -Linear
1.369 1 .242
Association
N of Valid Cases 303
a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 7.
72.
 84

Ensefalopati * Survival rate Crosstabulation

Surv iv al rate
Meninggal Hidup Total
Ensef alopati grade I-II Count 5 27 32
% within Surv iv al rate 12.5% 84.4% 44.4%
% of Total 6.9% 37.5% 44.4%
grade III-IV Count 35 5 40
% within Surv iv al rate 87.5% 15.6% 55.6%
% of Total 48.6% 6.9% 55.6%
Total Count 40 32 72
% within Surv iv al rate 100.0% 100.0% 100.0%
% of Total 55.6% 44.4% 100.0%

Ascites * Survival rate Crosstabul ation

Surv iv al rate
Meninggal Hidup Total
Ascites ringan-sedang Count 36 143 179
% wit hin Surv iv al rate 76.6% 81.3% 80.3%
% of Total 16.1% 64.1% 80.3%
berat Count 11 33 44
% wit hin Surv iv al rate 23.4% 18.8% 19.7%
% of Total 4.9% 14.8% 19.7%
Total Count 47 176 223
% wit hin Surv iv al rate 100.0% 100.0% 100.0%
% of Total 21.1% 78.9% 100.0%
 85

Tahun * Survival rate Crosstabulation

Surv iv al rate
Meninggal Hidup Total
Tahun 2010 Count 22 90 112
% wit hin Surv iv al rat e 36.7% 37.0% 37.0%
% of Total 7.3% 29.7% 37.0%
2011 Count 22 101 123
% wit hin Surv iv al rat e 36.7% 41.6% 40.6%
% of Total 7.3% 33.3% 40.6%
2012 Count 16 52 68
% wit hin Surv iv al rat e 26.7% 21.4% 22.4%
% of Total 5.3% 17.2% 22.4%
Total Count 60 243 303
% wit hin Surv iv al rat e 100.0% 100.0% 100.0%
% of Total 19.8% 80.2% 100.0%

Klasifikasi CHILD-PUGH * Survival rate

Crosstab

Surv iv al rate
Meninggal Hidup Total
Klasif ikasi A Count 0 15 15
CHI LD-PUGH % within Surv iv al rate .0% 8.2% 6.4%
% of Total .0% 6.4% 6.4%
B Count 4 71 75
% within Surv iv al rate 7.7% 39.0% 32.1%
% of Total 1.7% 30.3% 32.1%
C Count 48 96 144
% within Surv iv al rate 92.3% 52.7% 61.5%
% of Total 20.5% 41.0% 61.5%
Total Count 52 182 234
% within Surv iv al rate 100.0% 100.0% 100.0%
% of Total 22.2% 77.8% 100.0%
 86

Chi-Square Tests

Asy mp. Sig.

Value df (2-sided)
Pearson Chi-Square 26.949a 2 .000
Likelihood Ratio 33.354 2 .000
Linear-by -Linear
24.502 1 .000
Association
N of Valid Cases 234
a. 1 cells (16.7%) hav e expected count less t han 5. The
minimum expected count is 3.33.
 87

Lampiran 3. Tabel Frekuensi dari beberapa Variabel

Variabel Frekuensi Prosentase

Jenis kelamin
Laki-laki 205 67,7
Perempuan 98 32,3
Usia
< 31 tahun 10 3,3
31 – 40 tahun 21 6,9
41 – 50 tahun 79 26,1
51 – 60 tahun 104 34,3
61 – 70 tahun 59 19,5
> 70 tahun 30 9,9
Keluhan utama
Perut membesar 111 36,4
Nyeri perut 17 5,6
Berak darah 32 10,5
Muntah darah 63 20,7
Badan lemas 15 4,9
Penurunan kesadaran 18 5,9
Mata kuning 13 4,3
Lain2 48 15,7
Etiologi
Virus
HBV 184 60,7
HCV 55 18,2
HBV dan HCV 17 30,9
Non Virus
NAFL 21 6,9
Lain-lain 59 19,5
Klasifikasi CHILD-PUGH
A 15 6,4
B 75 32,1
C 144 61,5
Komplikasi
Perdarahan varises esophagus 59 19,5
 88

Ensefalopati Hepatikum 66 21,8

Karsinoma hepatoseluler 34 11,2
Sindrom hepatorenal 5 1,7
Hematemesis 79 26,1
Melena 85 28,1
Ascites 224 73,9
Peritonitis bacterial spontan 1 0,3
Gastropati HT Porta 29 12,9
Komorbid
Efusi pleura 38 12,5
Pneumonia 37 12,2
TB paru 5 1,7
Syok 7 2,3
Sepsis 19 6,3
Penyakit ginjal 10 3,3
Penyakit jantung 3 1
Ensefalopati Hepatikum
Tidak ada 233 76,4
Grade I-II 32 10,5
Grade III-IV 40 13,1
Ascites
Tidak ada 81 26,6
Ringan-sedang 180 59
Berat 44 14,4
Survival rate
Meninggal 60 19,8
Hidup 243 80,2
 89

Lampiran 4. Tabel Tabulasi Silang Berdasarkan Survival Rate

Status
Variabel Meninggal Hidup Jumlah
n % n % n %
Jenis kelamin
Laki-laki 39 65 166 68,3 205 67,7
Perempuan 21 35 77 31,7 98 32,3
Usia
< 31 tahun 1 1,7 9 3,7 10 3,3
31 – 40 tahun 3 5 18 7,4 21 6,9
41 – 50 tahun 15 25 64 26,3 79 26,1
51 – 60 tahun 19 31,7 85 35 104 34,3
61 – 70 tahun 15 25 44 18,1 59 19,5
> 70 tahun 7 11,7 23 9,5 30 9,9
Etiologi
Virus
HBV 35 58,3 149 61,3 184 60,7
HCV 8 13,3 47 19,3 55 18,2
HBV dan HCV 4 50 13 27,7 17 30,9
Non Virus
NAFL 3 5 18 7,4 21 6,9
Lain-lain 18 30 41 16,9 59 19,5
Klasifikasi CHILD-PUGH
A 0 0 15 8,2 15 6,4
B 4 7,7 71 39 75 32,1
C 48 92,3 96 52,7 144 61,5
Komplikasi
Perdarahan varises esophagus 7 11,7 52 21,4 59 19,5
Ensefalopati hepatikum 41 68,3 25 10,3 66 21,8
Karsinoma hepatoseluler 5 8,3 29 11,9 34 11,2
Sindroma hepatorenal 2 3,3 3 1,2 5 1,7
Hematemesis 17 28,3 62 25,5 79 26,1
Melena 18 30 67 27,6 85 28,1
Ascites 47 78,3 177 72,8 224 73,9
 90

Peritonitis bakterial spontan 1 1,7 0 0 1 0,3

Gastropati HT Porta 5 8,3 34 14 39 12,9

Komorbid
Efusi pleura 3 5 35 14,4 38 12,5
Pneumonia 15 25 22 9,1 37 12,2
TB paru 0 0 5 2,1 5 1,7
Syok 7 11,7 0 0 7 2,3
Sepsis 18 30 1 0,4 19 6,3
Penyakit ginjal 4 6,7 6 2,5 10 3,3
Penyakit jantung 0 0 3 1,2 3 1
Ensefalopati Hepatikum
Grade I-II 5 12,5 27 84,4 32 44,4
Grade III-IV 35 87,5 5 15,6 40 55,6
Ascites
Ringan-sedang 36 76,6 143 81,3 179 80,3
Berat 11 23,4 33 18,8 44 19,7
Tahun
2010 22 36,7 90 37 112 37
2011 22 36,7 101 41,6 123 40,6
2012 16 26,7 52 21,4 68 22,4
 91

Tabel uji normalitas kolmogorov smirnov

Variabel p

Usia 0,193

Bilirubin Total 0,000

Albumin serum 0,246

PPT 0,000

Lama perawatan 0,000

Tabel deskriptif

Variabel N Mean SD

Usia 303 54,17 11,755

Albumin serum 259 2,345 0,6009

Variabel N Median Min. Max.

Bilirubin Total 245 1,98 0,11 36,31

PPT 226 5,3 -0,9 106,3

Lama perawatan 303 9 0 48

Tabel Chi Square Klasifikasi CHILD-PUGH terhadap Survival rate

 92

Status
Klasifikasi
Meninggal Hidup Jumlah p
CHILD-PUGH
n % n % n %
A 0 0 15 8,2 15 6,4 < 0,001
B 4 7,7 71 39 75 32,1
C 48 92,3 96 52,7 144 61,5

Dari uji Chi Square antara Klasifikasi CHILD-PUGH terhadap status survival
didapatkan nilai p = < 0,001, karena p < 0,05 maka dapat disimpulkan terdapat
hubungan yang signifikan antara klasifikasi CHILD-PUGH dengan status survival.
 93

Tabel sebaran usia berdasarkan survival rate

Survival Rate
Usia Meninggal Hidup p
n (60) % n (243) %
< 31 1 1,7 9 3,7 0,761£
31 – 40 3 5 18 7,4
41 – 50 15 25 64 26,3
51 – 60 19 31,7 85 35
61 – 70 15 25 44 18,1
> 70 7 11,7 23 9,5
Keterangan :
£
Pearson Chi Square

Tabel Hubungan comorbid terhadap survival rate

Survival Rate
Comorbid Meninggal Hidup p
n (60) % n (243) %
Efusi pleura 3 5 35 14,4 0,049*£
Pneumonia 15 25 22 9,1 0,001*£
TB paru 0 0 5 2,1 0,587¥
Syok 7 11,7 0 0 0,000*¥
Sepsis 18 30 1 0,4 0,000*¥
Penyakit ginjal 4 6,7 6 2,5 0,114¥
Penyakit jantung 0 0 3 1,2 1,000¥
Keterangan :

* Signifikan p < 0,05

£
Pearson Chi Square
 94

¥
Fisher’s Exact Test

Tabel Hubungan komplikasi terhadap survival rate

Survival Rate
Komplikasi Meninggal Hidup p
n (60) % n (243) %
Perdarahan varises Esofagus 7 11,7 52 21,4 0,088£
Ensefalopati Hepatikum 41 68,3 25 10,3 0,001*£
Karsinoma Hepatoseluler 5 8,3 29 11,9 0,429£
Sindroma Hepatorenal 2 3,3 3 1,2 0,258¥
Hematemesis 17 28,3 62 25,5 0,656£
Melena 18 30 67 27,6 0,708£
Ascites 47 78,3 177 72,8 0,385£
Peritonitis bacterial spontan 1 1,7 0 0 0,198¥
Gastropati HT Porta 5 8,3 34 14 0,241£
Keterangan :

* Signifikan p < 0,05

£
Pearson Chi Square
¥
Fisher’s Exact Test
 95

Lampiran 5. Ethical Clearance

 96

Lampiran 6. Surat Permohonan Peminjaman Rekam Medis

 97

Lampiran 7. Dokumentasi Penelitian

 98

Lampiran 8. Biodata Mahasiswa

Identitas

Nama : Ni Made Tuty Marselina

NIM : 22010110110031

Tempat / tanggal lahir : Denpasar, 23 Maret 1992

Jenis Kelamin : Perempuan

Alamat : Jl. Tanah Putih II No.8 RT03 RW02, Semarang

Nomor HP : 085737105588

E-mail : tuty.marselina@rocketmail.com

Riwayat Pendidikan Formal

1. SD : 1998 Lulus tahun : 2004

2. SMP : 2004 Lulus tahun : 2007

3. SMA : 2007 Lulus tahun : 2010

4. FK UNDIP : Masuk tahun 2010